{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:31:58Z","timestamp":1793215918223,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health and Health Services Research Fund, by Food and Health Bureau, Hong Kong Special Administration Region","award":["14151701"],"award-info":[{"award-number":["14151701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00406-025-02185-8","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:29:54Z","timestamp":1767702594000},"page":"2885-2894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dopamine synthesis capacity in patients with remitted psychosis: correlates and one year outcome on relapse"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6912-208X","authenticated-orcid":false,"given":"Christy Lai Ming","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie Cheuk Lam","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Cai Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Man Hei","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Wing Man","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie Chi Yuen","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchen Tiffany","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise Chun Ning","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Nam","family":"Suen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yim Lung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett Chi Lai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys Goh","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Wai Hong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Song","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lap Tak","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Sai Yu","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin Ho Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry Kit Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yu Hai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2185_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-244X-13-50","volume":"13","author":"R Emsley","year":"2013","unstructured":"Emsley R, Chiliza B, Asmal L et al (2013) The nature of relapse in schizophrenia. BMC Psychiatry 13:50. https:\/\/doi.org\/10.1186\/1471-244X-13-50","journal-title":"BMC Psychiatry"},{"key":"2185_CR2","doi-asserted-by":"publisher","first-page":"c4024","DOI":"10.1136\/bmj.c4024","volume":"341","author":"EYH Chen","year":"2010","unstructured":"Chen EYH, Hui CLM, Lam MML et al (2010) Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial. BMJ 341:c4024. https:\/\/doi.org\/10.1136\/bmj.c4024","journal-title":"BMJ"},{"key":"2185_CR3","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS, Ko G et al (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474\u20131486. https:\/\/doi.org\/10.1176\/ajp.148.11.1474","journal-title":"Am J Psychiatry"},{"key":"2185_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes OD, Kambeitz J, Kim E et al (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Arch Gen Psychiatry 69:776\u2013786. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2012.169","journal-title":"Arch Gen Psychiatry"},{"key":"2185_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/mp.2011.20","volume":"16","author":"OD Howes","year":"2011","unstructured":"Howes OD, Bose SK, Turkheimer F et al (2011) Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry 16:885\u2013888. https:\/\/doi.org\/10.1038\/mp.2011.20","journal-title":"Mol Psychiatry"},{"key":"2185_CR6","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.2174\/138161212799316217","volume":"18","author":"OD Howes","year":"2012","unstructured":"Howes OD, Fusar-Poli P, Bloomfield M et al (2012) From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Curr Pharm Des 18:3394\u20133410. https:\/\/doi.org\/10.2174\/138161212799316217","journal-title":"Curr Pharm Des"},{"key":"2185_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.schres.2013.08.010","volume":"150","author":"CLM Hui","year":"2013","unstructured":"Hui CLM, Wong GHY, Tang JYM et al (2013) Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis. Schizophr Res 150:297\u2013302. https:\/\/doi.org\/10.1016\/j.schres.2013.08.010","journal-title":"Schizophr Res"},{"key":"2185_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1744-859X-12-32","volume":"12","author":"JM Olivares","year":"2013","unstructured":"Olivares JM, Sermon J, Hemels M et al (2013) Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review. Ann Gen Psychiatry 12:50. https:\/\/doi.org\/10.1186\/1744-859X-12-32","journal-title":"Ann Gen Psychiatry"},{"key":"2185_CR9","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1038\/s41380-020-00879-0","volume":"26","author":"S Kim","year":"2020","unstructured":"Kim S, Shin SH, Santangelo B et al (2020) Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [18F]DOPA and [11\u00a0C]raclopride PET study in first-episode psychosis. Mol Psychiatry 26:3476\u20133488. https:\/\/doi.org\/10.1038\/s41380-020-00879-0","journal-title":"Mol Psychiatry"},{"key":"2185_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/brain\/awz093","volume":"142","author":"M Avram","year":"2019","unstructured":"Avram M, Brandl F, Cabello J et al (2019) Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain 142:1813\u20131826. https:\/\/doi.org\/10.1093\/brain\/awz093","journal-title":"Brain"},{"key":"2185_CR11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","volume":"74","author":"S Jauhar","year":"2017","unstructured":"Jauhar S, Nour MM, Veronese M et al (2017) A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 74:1206\u20131213. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.2943","journal-title":"JAMA Psychiatry"},{"key":"2185_CR12","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/s41386-020-0740-x","volume":"45","author":"PWC Cheng","year":"2020","unstructured":"Cheng PWC, Chang WC, Lo GG et al (2020) The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a PET study comparing schizophrenia, delusional disorder, and other psychotic disorders. Neuropsychopharmacology 45:1870\u20131876. https:\/\/doi.org\/10.1038\/s41386-020-0740-x","journal-title":"Neuropsychopharmacology"},{"key":"2185_CR13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41386-020-00866-7","volume":"46","author":"M Veronese","year":"2021","unstructured":"Veronese M, Santangelo B, Jauhar S et al (2021) A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach. Neuropsychopharmacology 46:1122\u20131132. https:\/\/doi.org\/10.1038\/s41386-020-00866-7","journal-title":"Neuropsychopharmacology"},{"key":"2185_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.10.4923","volume":"195","author":"MC Adams","year":"2010","unstructured":"Adams MC, Turkington TG, Wilson JM et al (2010) A systematic review of the factors affecting accuracy of SUV measurements. Am J Roentgenol 195:310\u2013320. https:\/\/doi.org\/10.2214\/AJR.10.4923","journal-title":"Am J Roentgenol"},{"key":"2185_CR15","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington. https:\/\/doi.org\/10.1176\/appi.books.9780890425596","edition":"5"},{"key":"2185_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen NC, Carpenter WT, Kane JM et al (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162:441\u2013449. https:\/\/doi.org\/10.1176\/appi.ajp.162.3.441","journal-title":"Am J Psychiatry"},{"key":"2185_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276. https:\/\/doi.org\/10.1093\/schbul\/13.2.261","journal-title":"Schizophr Bull"},{"key":"2185_CR18","doi-asserted-by":"publisher","unstructured":"Guy W (1976) ECDEU assessment manual for psychopharmacology. U.S. Department of Health, Education, and Welfare. https:\/\/doi.org\/10.1037\/e591322011-001","DOI":"10.1037\/e591322011-001"},{"key":"2185_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0920-9964(92)90003-n","volume":"6","author":"D Addington","year":"1992","unstructured":"Addington D, Addington J, Maticka-Tyndale E et al (1992) Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 6:201\u2013208. https:\/\/doi.org\/10.1016\/0920-9964(92)90003-n","journal-title":"Schizophr Res"},{"key":"2185_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1176\/ajp.150.6.873","volume":"150","author":"XF Amador","year":"1993","unstructured":"Amador XF, Strauss DH, Yale SA et al (1993) Assessment of insight in psychosis. Am J Psychiatry 150:873\u2013879. https:\/\/doi.org\/10.1176\/ajp.150.6.873","journal-title":"Am J Psychiatry"},{"key":"2185_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"76","author":"O Lingj\u00e6rde","year":"1987","unstructured":"Lingj\u00e6rde O, Ahlfors UG, Bech P et al (1987) The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76:1\u2013100. https:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb10566.x","journal-title":"Acta Psychiatr Scand"},{"key":"2185_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1176\/ajp.149.9.1148","volume":"149","author":"HH Goldman","year":"1992","unstructured":"Goldman HH, Skodol AE, Lave TR (1992) Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 149:1148\u20131156. https:\/\/doi.org\/10.1176\/ajp.149.9.1148","journal-title":"Am J Psychiatry"},{"key":"2185_CR23","doi-asserted-by":"publisher","unstructured":"Heinze G, Ploner M, Jiricka L (2025) Logistf: firth\u2019s Bias-Reduced logistic regression. https:\/\/doi.org\/10.32614\/CRAN.package.logistf","DOI":"10.32614\/CRAN.package.logistf"},{"key":"2185_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-023-00962-x","volume":"13","author":"A Iep","year":"2023","unstructured":"Iep A, Chawki MB, Goldfarb L et al (2023) Relevance of 18F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study. EJNMMI Res 13:1\u201312. https:\/\/doi.org\/10.1186\/s13550-023-00962-x","journal-title":"EJNMMI Res"},{"key":"2185_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1177\/1740774513506618","volume":"10","author":"BF Kurland","year":"2013","unstructured":"Kurland BF, Doot RK, Linden HM et al (2013) Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs. Clin Trials 10:886\u2013895. https:\/\/doi.org\/10.1177\/1740774513506618","journal-title":"Clin Trials"},{"key":"2185_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, Murray RM, McGuire PK et al (2012) Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry 169:1203\u20131210. https:\/\/doi.org\/10.1176\/appi.ajp.2012.12010144","journal-title":"Am J Psychiatry"},{"key":"2185_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2008.11.006","volume":"108","author":"S Nozaki","year":"2009","unstructured":"Nozaki S, Kato M, Takano H et al (2009) Regional dopamine synthesis in patients with schizophrenia using L-[\u03b2-11\u00a0C]DOPA PET. Schizophr Res 108:78\u201384. https:\/\/doi.org\/10.1016\/j.schres.2008.11.006","journal-title":"Schizophr Res"},{"key":"2185_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/s0006-3223(02)01369-0","volume":"52","author":"A Laakso","year":"2002","unstructured":"Laakso A, Vilkman H, Bergman J et al (2002) Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry 52:759\u2013763. https:\/\/doi.org\/10.1016\/s0006-3223(02)01369-0","journal-title":"Biol Psychiatry"},{"key":"2185_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4088\/jcp.08r04171","volume":"70","author":"H Uchida","year":"2009","unstructured":"Uchida H, Mamo DC, Mulsant BH et al (2009) Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms. J Clin Psychiatry 70:397\u2013405. https:\/\/doi.org\/10.4088\/jcp.08r04171","journal-title":"J Clin Psychiatry"},{"key":"2185_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopsych.2018.07.003","volume":"85","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Veronese M, Nour MM et al (2019) The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: a positron emission tomography study. Biol Psychiatry 85:79\u201387. https:\/\/doi.org\/10.1016\/j.biopsych.2018.07.003","journal-title":"Biol Psychiatry"},{"key":"2185_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","volume":"66","author":"OD Howes","year":"2009","unstructured":"Howes OD, Montgomery AJ, Asselin MC et al (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66:13\u201320. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2008.514","journal-title":"Arch Gen Psychiatry"},{"key":"2185_CR32","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41380-018-0042-4","volume":"24","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Veronese M, Nour MM et al (2019) Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study. Mol Psychiatry 24:1502\u20131512. https:\/\/doi.org\/10.1038\/s41380-018-0042-4","journal-title":"Mol Psychiatry"},{"key":"2185_CR33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/npp.2016.258","volume":"42","author":"E Kim","year":"2017","unstructured":"Kim E, Howes OD, Veronese M et al (2017) Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [18F]DOPA PET study. Neuropsychopharmacology 42:941\u2013950. https:\/\/doi.org\/10.1038\/npp.2016.258","journal-title":"Neuropsychopharmacology"},{"key":"2185_CR34","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/schbul\/sbab017","volume":"47","author":"MA Horowitz","year":"2021","unstructured":"Horowitz MA, Jauhar S, Natesan S et al (2021) A method for tapering antipsychotic treatment that May minimize the risk of relapse. Schizophr Bull 47:1116\u20131129. https:\/\/doi.org\/10.1093\/schbul\/sbab017","journal-title":"Schizophr Bull"},{"key":"2185_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.npp.1300103","volume":"28","author":"G Gr\u00fcnder","year":"2003","unstructured":"Gr\u00fcnder G, Vernaleken I, M\u00fcller MJ et al (2003) Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology 28:787\u2013794. https:\/\/doi.org\/10.1038\/sj.npp.1300103","journal-title":"Neuropsychopharmacology"},{"key":"2185_CR36","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S2215-0366(18)30090-7","volume":"5","author":"CLM Hui","year":"2018","unstructured":"Hui CLM, Honer WG, Lee EHM et al (2018) Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial. Lancet Psychiatry 5:432\u2013442. https:\/\/doi.org\/10.1016\/S2215-0366(18)30090-7","journal-title":"Lancet Psychiatry"},{"key":"2185_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1176\/appi.ajp.162.1.12","volume":"162","author":"E Cantor-Graae","year":"2005","unstructured":"Cantor-Graae E, Selten JP (2005) Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162:12\u201324. https:\/\/doi.org\/10.1176\/appi.ajp.162.1.12","journal-title":"Am J Psychiatry"},{"key":"2185_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/schbul\/sbw181","volume":"43","author":"A Egerton","year":"2017","unstructured":"Egerton A, Howes OD, Houle S et al (2017) Elevated striatal dopamine function in immigrants and their children: a risk mechanism for psychosis. Schizophr Bull 43:293\u2013301. https:\/\/doi.org\/10.1093\/schbul\/sbw181","journal-title":"Schizophr Bull"},{"key":"2185_CR39","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","volume":"383","author":"OD Howes","year":"2014","unstructured":"Howes OD, Murray RM (2014) Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet 383:1677\u20131687. https:\/\/doi.org\/10.1016\/S0140-6736(13)62036-X","journal-title":"Lancet"},{"key":"2185_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","volume":"56","author":"D Robinson","year":"1999","unstructured":"Robinson D, Woerner MG, Alvir JMJ et al (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56:241\u2013247. https:\/\/doi.org\/10.1001\/archpsyc.56.3.241","journal-title":"Arch Gen Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-02185-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:02:19Z","timestamp":1788019339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-02185-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-02185-8","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EYHC has participated in the paid advisory board for Otsuka and received educational grant support from Janssen-Cilag. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}